Oncogenetic landscape of lymphomagenesis in coeliac disease

JAK–STAT pathway targeting for the treatment of inflammatory bowel disease

(2020) Azucena Salas et al.   Nature Reviews Gastroenterology & Hepatology

BCOR involvement in cancer

(2019) Annalisa Astolfi et al.   Epigenomics

Dysregulation of the TET family of epigenetic regulators in hematopoietic malignancies

(2019) Chan-Wang J. Lio et al.   BLOOD

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract

(2019) Craig R. Soderquist et al.   HAEMATOLOGICA

SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis

(2019) Batham et al.   Cancers

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

(2019) Camille Laurent et al.   BLOOD

Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis

(2019) Melinda J. Gooderham et al.   JAMA Dermatology

RecurrentSTAT3-JAK2fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract

(2018) Ayush Sharma et al.   BLOOD

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms

(2018) Maria Kleppe et al.   CANCER CELL

The molecular basis of JAK/STAT inhibition by SOCS1

(2018) Nicholas P. D. Liau et al.   Nature Communications

Epidemiology of Celiac Disease

(2018) Jonas F. Ludvigsson et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study

(2018) Morgane Cheminant et al.   GUT

The wide spectrum of POT1 gene variants correlates with multiple cancer types

(2017) Oriol Calvete et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition

(2017) Bernd Groner et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes

(2017) Yvonne M. C. Kooy-Winkelaar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteasome inhibitors: structure and function

(2017) Ana T. Nunes et al.   SEMINARS IN ONCOLOGY

Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease

(2016) Julien Ettersperger et al.   IMMUNITY

Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma

(2016) Xing Bao et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma

(2016) M-L Nairismägi et al.   LEUKEMIA

Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas

(2016) A Nicolae et al.   LEUKEMIA

Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?

(2016) Ewa M. Michalak et al.   Molecular Oncology

Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

(2016) Annalisa Roberti et al.   Nature Communications

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

(2015) Ramona Crescenzo et al.   CANCER CELL

The Ying and Yang of STAT3 in Human Disease

(2015) Tiphanie P. Vogel et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma

(2015) Lu Jiang et al.   NATURE GENETICS

Integrated molecular analysis of adult T cell leukemia/lymphoma

(2015) Keisuke Kataoka et al.   NATURE GENETICS

Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study

(2013) Georgia Malamut et al.   DIGESTIVE AND LIVER DISEASE

Celiac Disease: An Immunological Jigsaw

(2012) Bertrand Meresse et al.   IMMUNITY

Refractory celiac disease: from bench to bedside

(2012) Georgia Malamut et al.   Seminars in Immunopathology

Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus

(2010) Julia Strebovsky et al.   FASEB JOURNAL

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

(2010) F. Baran-Marszak et al.   HAEMATOLOGICA

ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling

(2009) Lynn Verstrepen et al.   BIOCHEMICAL PHARMACOLOGY

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

(2009) Sergei I. Grivennikov et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF- B signalling

(2009) G. Trynka et al.   GUT

Clinical Staging and Survival in Refractory Celiac Disease: A Single Center Experience

(2008) Alberto Rubio–Tapia et al.   GASTROENTEROLOGY

Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II

(2008) Georgia Malamut et al.   GASTROENTEROLOGY

Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor- B pathways in subtypes of diffuse large B-cell lymphoma

(2007) L. T. Lam et al.   BLOOD